Aldeyra Therapeutics, Inc.

Historical 13F Holders

Symbol
ALDX
CUSIP
01438T106
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 01438T106 since 12/18/2024, largest first.

Filer % of Class Filed
Barclays PLC 13G 5.5% 11/6/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
BlackRock, Inc. 13G/A 1.7% 7/27/2026
Event 6/30/2026
AQR Capital Management, LLC 13G/A
1.1% 11/12/2026
Event 9/30/2026
Perceptive Advisors LLC 13G/A
0% 5/15/2026
Event 3/31/2026
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 100 31.0 M $38.1M
2026 Q2 107 36.5 M $77.7M
2026 Q1 128 37.3 M $63.3M
2025 Q4 138 39.0 M $202M
2025 Q3 131 39.1 M $204M
2025 Q2 124 34.1 M $131M
2025 Q1 129 37.9 M $226M
2024 Q4 121 37.2 M $186M
2024 Q3 114 36.7 M $250M
2024 Q2 104 35.3 M $117M
2024 Q1 104 35.4 M $116M
2023 Q4 106 35.1 M $124M
2023 Q3 121 37.8 M $252M
2023 Q2 120 39.0 M $328M
2023 Q1 111 35.6 M $353M
2022 Q4 98 34.2 M $238M
2022 Q3 92 37.0 M $197M
2022 Q2 98 37.0 M $147M
2022 Q1 115 38.6 M $172M
2021 Q4 122 36.5 M $147M
2021 Q3 122 39.7 M $349M
2021 Q2 141 45.3 M $515M
2021 Q1 110 31.7 M $377M
2020 Q4 100 22.4 M $155M
2020 Q3 88 23.8 M $176M
2020 Q2 85 14.6 M $61.1M
2020 Q1 73 16.8 M $41.4M
2019 Q4 78 17.7 M $103M
2019 Q3 73 16.9 M $88.9M
2019 Q2 77 16.9 M $102M
2019 Q1 83 16.4 M $148M
2018 Q4 78 17.2 M $141M
2018 Q3 93 18.1 M $249M
2018 Q2 66 12.2 M $96.6M
2018 Q1 45 10.3 M $77.1M
2017 Q4 38 9.78 M $66.5M
2017 Q3 36 9.22 M $66.4M
2017 Q2 26 7.44 M $34.7M
2017 Q1 24 7.90 M $38.0M
2016 Q4 20 6.14 M $32.8M
2016 Q3 22 6.11 M $47.9M
2016 Q2 25 6.36 M $36.2M
2016 Q1 28 4.37 M $18.3M
2015 Q4 21 4.43 M $30.0M
2015 Q3 22 4.33 M $25.2M
2015 Q2 24 4.23 M $32.9M
2015 Q1 15 1.69 M $17.4M
2014 Q4 5 870 k $6.28M
2014 Q3 7 859 k $5.16M
2014 Q2 7 852 k $5.64M